Results 111 to 120 of about 11,622 (186)

Pseudolaric Acid B Combats Drug‐Resistant Candida albicans Infection via Dual‐Action Mechanisms of Direct Antifungals and Vaginal Microbiota Restoration

Microbial Biotechnology, Volume 19, Issue 3, March 2026.
We propose a novel therapeutic approach against fungal infection: Pseudolaric acid B directly eradicates C. albicans via Erg11 inhibition and uniquely, restores vaginal microecological homeostasis by promoting probiotic lactobacilli, addressing both the pathogen and the dysbiotic environment.
Tianmeng Shao, Yunshan Zhang, Binqing Xue, Weihua Chu   +3 more
wiley   +1 more source

Gut mycobiome alterations and implications for liver diseases.

PLoS Pathogens
Chronic liver disease and its complications are a significant global health burden. Changes in fungal communities (mycobiome), an integral component of the gut microbiome, are associated with and contribute to the development of liver disease.
Suling Zeng, Bernd Schnabl
doaj   +1 more source

Bacterial Extracellular Vesicles in the Pathogenesis and Treatment of Liver Diseases

Journal of Gastroenterology and Hepatology, Volume 41, Issue 3, Page 880-894, March 2026.
Liver diseases are a major global health challenge, with current treatments inadequate. This review highlights the role of bacterial extracellular vesicles in liver inflammation, fibrosis, and metabolism. We also explore these from commensals and probiotics, their protective effects, and discuss research challenges and future therapeutic potential ...
Yakun Li, Jia Li, Robin P. F. Dullaart, Han Moshage   +3 more
wiley   +1 more source

Lack of Structural Change in Olfactory Circuitry Following Fecal Microbiome Transplant From Donors Subjected to Diet‐induced Obesity

Journal of Neurochemistry, Volume 170, Issue 3, March 2026.
Fecal microbiome transplant from obese donor mice evokes microbiota changes that are not sufficient to change olfactory synaptic structure or glucose sensitivity in control‐fat (CF) fed recipient mice. FMT CF, fecal microbiome transplantation from control‐fat (CF) fed donors; FMT MHF, fecal microbiome transplantation from moderately high‐fat (MHF) fed ...
Ashley M. Loeven, Franklin A. Pacheco, Amber N. Brown, Debra Ann Fadool   +3 more
wiley   +1 more source

Complex of intratumoral mycobiome and bacteriome predicts the recurrence of laryngeal squamous cell carcinoma

Applied and Environmental Microbiology
Dysbiosis of intratumoral fungal and bacterial communities is associated with poor prognosis in various cancers. However, the mycobiome characteristics in laryngeal squamous cell carcinoma (LSCC) and its correlation with recurrence have not yet been ...
Xinhui Mao, Huiying Huang, Limin Zhao, Feiran Li, Zhenwei Wang, Xiaohui Yuan, Hui-Ching Lau, Chi-Yao Hsueh, Ming Zhang   +8 more
doaj   +1 more source

P858 Crohn’s disease is characterised by a fungal dysbiosis [PDF]

Journal of Crohn's and Colitis, 2018
A Frau, D Jonkers, J Penders, M Pierik, U Z Ijaz, B Campbell, A Darby, J Kenny, N Hall, C Probert   +9 more
openaire   +1 more source

Integrating the Microbiome Into Infection Ecology and Evolution in Wild Animals

Molecular Ecology, Volume 35, Issue 5, March 2026.
ABSTRACT Parasites are a ubiquitous force in nature threatening wildlife populations and ecosystems. Interactions between hosts and their parasites are impacted by host‐associated microbiomes, which are essential for host development, physiology and immunity.
Jingdi Li, Ian Will, Luís M. Silva, Tommy J. Travers‐Cook, Paradyse E. Blackwood, Kayla C. King   +5 more
wiley   +1 more source

Gut mycobiome in metabolic diseases: Mechanisms and clinical implication

Biomedical Journal
Obesity, type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD) are three common metabolic diseases with high prevalence worldwide.
Xingyu Zhou, Xiang Zhang, Jun Yu
doaj   +1 more source

Mechanistic Insights for Microbiome Application in Plant Disease Resistance

Molecular Plant Pathology, Volume 27, Issue 3, March 2026.
This review summarises the mechanisms underlying plant‐guided microbiome modulation and probiotic‐mediated disease suppression. Additionally, it highlights the challenges to be addressed for a better microbiome application of disease resistance in sustainable agriculture and proposes possible strategies. Figure was created with BioRender.
Jiakang Yin
wiley   +1 more source

Dysbiosis in fungal microbiota in IBD [PDF]

Nature Reviews Gastroenterology & Hepatology, 2016
openaire   +1 more source